Hematology
Volume 28, 2023 - Issue 1
Open access
750
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Cell division cycle 37 change after bortezomib-based induction therapy helps to predict clinical response and prognosis in multiple myeloma patients
Wuqiang LinDepartment of Hematology, The First Hospital of Putian City, Putian, People’s Republic of ChinaCorrespondence[email protected]
, Xiuli ChenDepartment of Hematology, The First Hospital of Putian City, Putian, People’s Republic of China
, Heyong ZhengDepartment of Hematology, The First Hospital of Putian City, Putian, People’s Republic of China
& Zhenjie CaiDepartment of Hematology, The First Hospital of Putian City, Putian, People’s Republic of China
Article: 2231741
|
Received 25 Feb 2023, Accepted 27 Jun 2023, Published online: 06 Jul 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.